BeOne Medicines Sets 22 May 2026 Record Date for Annual General Meeting Attendance

Bulletin Express04-28

BeOne Medicines Ltd. has fixed 12:00 p.m. Central European Summer Time (6:00 p.m. Hong Kong time) on Friday, 22 May 2026 as the record date for determining shareholder eligibility to attend and vote at its 2026 Annual General Meeting (AGM).

Shareholders intending to participate in the AGM must ensure that properly completed transfer forms, together with the corresponding share certificates, reach the company’s Hong Kong branch share registrar—Computershare Hong Kong Investor Services Limited, Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wan Chai—no later than 4:30 p.m. Hong Kong time on the same day, 22 May 2026.

Details regarding the AGM’s exact date, time and venue are available in the meeting notice and proxy materials published on 28 April 2026 via the Hong Kong Stock Exchange website.

The board of BeOne Medicines currently comprises: • Chairman and Executive Director: Mr. John V. Oyler • Non-executive Director: Dr. Xiaodong Wang • Independent Non-executive Directors: Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Mr. Michael Goller, Mr. Anthony C. Hooper, Mr. Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Ms. Shalini Sharp and Mr. Qingqing Yi

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment